Abstract
Background
Mediated via the androgen receptor on granulosa cells, models of small growing follicle stages demonstrate dependence on testosterone. Androgen deficiency reduces ovarian response to follicle stimulation hormone (FSH), granulosa cell mass and estradiol (E2) production falls and FSH, therefore, rises. Though potentially of adrenal and/or ovarian origin, androgen deficiency in association with female infertility is almost universally primarily of adrenal origin, raising the possibility that women with presumptive diagnosis of primary ovarian insufficiency (POI), also called primary ovarian failure (POF) may actually suffer from secondary ovarian insufficiency (SOI) due to adrenal hypoandrogenism that leads to follicular arrest at small-growing follicle stages.
Methods
This retrospective cohort study was performed in a private, academically affiliated infertility center in New York City. We searched the center’s anonymized electronic research data bank for consecutive patients who presented with a diagnosis of POI, defined by age <41 year, FSH > 40.0 mIU/mL, amenorrhea for at least 6 month, and low testosterone (T), defined as total T (TT) in the lowest age-specific quartile of normal range. This study did not include patients with oophoritis. Since dehydroepiandrosterone sulfate (DHEAS) is the only androgen almost exclusively produce by adrenals, adrenal hypoandrogenism was defined by DHEAS < 100ug/dL. Thirteen of 78 presumed POI women (16.67%) qualified and represented the original study population. POI patients are usually treated with third-party egg donation; 6/13, however, rejected egg donation for personal or religious reasons and insisted on undergoing at least one last IVF cycle attempt (final study population). In preparation, they were supplemented with DHEA 25 mg TID and CoQ10 333 mg TID for at least 6 weeks prior to ovarian stimulation for IVF with FSH and human menopausal gonadotropins (hMG). Since POI patients are expected to be resistant to ovarian stimulation, primary outcome for the study was ovarian response, while secondary outcome was pregnancy/delivery.
Results
Though POI/POF patients usually are completely unresponsive to ovarian stimulation, to our surprise, 5/6 (83.3%) patients demonstrated an objective follicle response. In addition, 2/6 (33.3%) conceived spontaneously between IVF cycles, while on DHEA and CoQ10 supplementation and delivered healthy offspring. One of those is currently in treatment for a second child.
Conclusions
This preliminary report suggests that a surprising portion of young women below age 41, tagged with a diagnosis of POI/POF, due to adrenal hypoandrogenism actually suffer from a form of SOI, at least in some cases amenable to treatment by androgen supplementation. Since true POI/POF usually requires third-party egg donation, correct differentiation between POI and SOI in such women appears of great importance and may warrant a trial stimulation after androgen pre-supplementation for at least 6 weeks.
Similar content being viewed by others
References
L.M. Nelson, Primary ovarian insufficiency. N. Engl. J. Med 360(6), 606–614 (2009)
P.A. van Noord, J.S. Dubas, M. Dorland, H. Boersma, E. te Velde, Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil. Steril. 68, 95–102 (1997)
Y.M. van Kasteren, J. Schoemaker, Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum. Reprod. Update 5, 483–492 (1999)
N. Gleicher, A. Kim, A. Weghofer, V.A. Kusjnir, A. Shohat-Tal, E. Lazzaroni, H.J. Lee, D.H. Barad, Hypoandrogenism in association with diminished functional ovarian reserve. Hum. Reprod. 28(4), 1084–1091 (2013)
H. Prizant, N. Gleicher, A. Sen, Androgen actions in the ovary: balance is key. J. Endocrinol. 222(3), R141–R151 (2014)
A. Sen, V.A. Kushnir, D.H. Barad, N. Gleicher, Endocrine autoimmune diseases and female infertility. Nat. Rev. Endocrinol. 10(1), 37–50 (2014)
N. Gleicher, V.A. Kushnir, A. Weghofer, D.H. Barad, The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency. Reprod. Biol. Endocrinol. 14, 23 (2016)
N. Gleicher, V.A. Kushnir, S.K. Darmon, Q. Wang, L. Zhang, D.F. Albertini, D.H. Barad, New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens. J. Steroid Biochem. Mol. Biol. 167, 144–152 (2017)
N. Gleicher, V.A. Kushnir, S.K. Darmon, Q. Wang, L. Zhang, D.F. Albertini, D.H. Barad, Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age. Endocrine 59(3), 661–676 (2018)
Y.G. Wu, D.H. Barad, V.A. Kushnir, E. Lazzaroni, Q. Wang, D.F. Albertini, N. Gleicher, Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J. Endocrinol. 226(3), 167–180 (2015)
Y.G. Wu, D.H. Barad, V.A. Kushnir, Q. Wang, L. Zhang, S.K. Darmon, D.F. Albertini, N. Gleicher, With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization. J. Ovarian Res. 11(1), 23 (2018)
Ethics Committee of the American Society for Reproductive Medicine., Fertility treatment when the prognosis is very poor or futile: committee opinion. Fertil. Steril. 98(1), e6–e9 (2012)
N. Gleicher, A. Weghofer, K. Oktay, D. Barad, Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF). Hum. Reprod. 24(10), 2395–2400 (2009)
C.K. Welt, Autoimmune oophoritis in the adolescent. Ann. NY Acad. Sci. 1135, 118–122 (2008)
C.C. Huang, H.H. Yao, Diverse functions of Hedgehog signaling in formation and physiology of steroidogenic organs. Mol. Reprod. Dev. 77(6), 489–496 (2010)
A. Grabek, B. Dolfi, B. Klein, F. Jian-Montamedi, M.-C. Chaboissier, The adult adrenal cortex undergoes rapid tissue renewal in a sex-specific manner. Cell Stem Cell 25, 290–296 (2019)
N. Gleicher, V.A. Kushnir, D.F. Albertini, D.H. Barad, Letter to the editor: Including the Zona Reticularis in the Definition of Hypoadrenalism and Hyperadrenalism. J. Clin. Endocrinol. Metab. 102(9), 3569–3570 (2017)
C. Dal Pra, S. Chen, J. Furmaniak, B. Rees Smith, A. Moscon, R. Zanchetta, C. Bettrle, Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure without Addison���s disease. Eur. J. Endoecinol. 148(5), 565–570 (2003)
S. Upadhyay, L. Zamboni, Ectopic germ cells: natural model for the study of germ cell sexual differentiation. Proc. Natl Acad. Sci. USA 79(21), 6584–6588 (1982)
T. Röhrig, M. Pihlajoki, R. Ziegler, R.S. Cochran, A. Schrade, M. Schillebeeckx, R.D. Mitra, M. Helkinhelmo, D.B. Wilson, Toying with fate: redirecting the differentiation of adrenocortical-progenitor cells into gonadal-like tissue. Mol. Cell Endocrinol. 408, 165–177 (2015)
J.C. Pattison, D.H. Abbott, W. Saltzman, A.J. Conley, I.M. Bird, Plasticity of the zona reticularis in the adult marmoset adrenal cortex: voyages of discovery in the New World. mJ Endocrinol 203(3), 313–326 (2009)
J.L. Naffin-Olivos, R.J. Auchus, Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17.n. Biochemistry 45(3), 755–762 (2006)
R. A. Anderson, What does anti-Müllerian hormone tell you about ovarian function? Clin. Edocrinol. 77(5), 652–655 (2012)
M. Bielinska, S. Kiiveri, H. Parviainen, S. Mannisto, M. Heikinheimo, D.B. Wilson, Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse. Vet. Pathol. 43(2), 97–117 (2006)
M. Schillebeeckx, M. Pihlajoki, E. Gretzinger, W. Yang, F. Thol, T. Hiller, A.K. Löbs, T. Röhrig, A. Schrade, R. Cochran, P.Y. Jay, M. Heikinheimo, R.D. Mitra, D.B. Wilson, Toying with fate: redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue. Mol. Cell Endocrinol. 5(399), 122–130 (2015)
Author contributions
Concept and design: Gleicher, Barad, Albertini Acquisition, analysis or interpretation of data: All authors. Drafting of manuscript: Gleicher. Critical revision of manuscript for important intellectual content: All authors. Data retrieval: Darmon Statistical analysis: n/a Obtained funding: Gleicher Administrative, technical or material support: Gleicher Supervision: Gleicher.
Financial support
This study was supported by intramural funds of CHR and the Foundation for Reproductive Medicine
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Drs. Gleicher and Barad are listed as co-inventors on a number of U.S. patents. Some of these patents relate to pre-supplementation of hypo-androgenic infertile women with androgens, such as DHEA and testosterone and, therefore, relate to the subject of this manuscript. N.G., D.F.A, and D.H.B. have received research support, travel funds and speaker honoraria from a number of pharmaceutical and medical device companies, though none related to here presented subjects and manuscript. Dr. Gleicher is a shareholder in Fertility Nutraceuticals, LLC. Drs. Gleicher and Barad receive royalty payments from Fertility Nutraceuticals LLC. That company’s over-the-counter products (DHEA and CoQ10) were used in this study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
APPENDIX
APPENDIX
Rights and permissions
About this article
Cite this article
Gleicher, N., Darmon, S., Molinari, E. et al. A form of secondary ovarian insufficiency (SOI) due to adrenal hypoandrogenism as new infertility diagnosis. Endocrine 72, 260–267 (2021). https://doi.org/10.1007/s12020-020-02512-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02512-0